Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Kawaguchi

Showing results (1-10 of 491) with videos related to

Pageof 50
Sort By:
Osteoarthritis and Cartilage|August 9, 2024
Current status of treatments administered by intra-articular injection for knee osteoarthritisHiroshi Kawaguchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 18, 2005
[Molecular mechanism of age-related osteoporosis]Hiroshi Kawaguchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|June 4, 2009
[Bench to bedside of osteoarthritis: where we are and to go]Hiroshi Kawaguchi
Clinical Calcium|April 29, 2009
[Bone fracture and the healing mechanisms. Fibroblast growth factor-2 and fracture healing]Hiroshi Kawaguchi
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification processHiroshi Kawaguchi
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2020
Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications WorldwideHiroshi Kawaguchi
Journal of Bone and Mineral Metabolism|February 18, 2025
Assessment of evidence for the off-label application of osteoanabolic drugs in fracture healing and spinal fusionHiroshi Kawaguchi
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 8, 2025
Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular riskHiroshi Kawaguchi
Bone|September 26, 2025
Structural challenges in using Japanese claims databases for real-world evidence in osteoporosis researchHiroshi Kawaguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 13, 2011
[Approach for therapeutic targets of osteoarthritis]Hiroshi Kawaguchi
Pageof 50

Showing results (1-10 of 491) with videos related to

Sort By:
Pageof 50
Osteoarthritis and Cartilage|August 9, 2024
Current status of treatments administered by intra-articular injection for knee osteoarthritisHiroshi Kawaguchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 18, 2005
[Molecular mechanism of age-related osteoporosis]Hiroshi Kawaguchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|June 4, 2009
[Bench to bedside of osteoarthritis: where we are and to go]Hiroshi Kawaguchi
Clinical Calcium|April 29, 2009
[Bone fracture and the healing mechanisms. Fibroblast growth factor-2 and fracture healing]Hiroshi Kawaguchi
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification processHiroshi Kawaguchi
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2020
Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications WorldwideHiroshi Kawaguchi
Journal of Bone and Mineral Metabolism|February 18, 2025
Assessment of evidence for the off-label application of osteoanabolic drugs in fracture healing and spinal fusionHiroshi Kawaguchi
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 8, 2025
Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular riskHiroshi Kawaguchi
Bone|September 26, 2025
Structural challenges in using Japanese claims databases for real-world evidence in osteoporosis researchHiroshi Kawaguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 13, 2011
[Approach for therapeutic targets of osteoarthritis]Hiroshi Kawaguchi
Pageof 50